Bronchiectasis is a chronic lung condition in which the airways (bronchi) become permanently widened and damaged, making it difficult to clear mucus. This trapped mucus creates a breeding ground for bacteria, leading to repeated infections that cause further damage over time. The condition affects more women than men and is most common in older adults, with prevalence rates that have been rising steadily over the past 25 years as diagnostic tools have improved.
What Happens Inside the Lungs
In healthy lungs, the airways are lined with tiny hair-like structures that sweep mucus and debris upward and out. In bronchiectasis, the walls of the airways become damaged and lose key structural components, specifically the elastic fibers, muscle, and cartilage that normally keep them firm and flexible. Without that scaffolding, the airways stretch open and can no longer contract effectively to push mucus out.
The damage comes primarily from immune cells, particularly a type of white blood cell called neutrophils, which flood into the airways in response to infection. These cells release powerful enzymes meant to kill bacteria, but those same enzymes also break down the airway walls. The result is airways that are wider than normal but functionally worse: floppy, inflamed, and clogged with thick mucus.
Doctors classify the widening into three patterns based on how it looks on imaging. Tubular bronchiectasis, the most common form, involves smooth, uniform dilation. Varicose bronchiectasis shows an uneven, beaded appearance. Cystic bronchiectasis, the most severe form, features airways that balloon out into sac-like pockets at their ends.
The Vicious Cycle That Drives It
Bronchiectasis tends to get worse over time because of a self-reinforcing loop. Some initial insult, often an infection, damages the airways enough to impair mucus clearance. Bacteria that would normally be swept out instead settle in and multiply. The immune system responds with inflammation, which damages the airway walls further, which makes mucus clearance even worse, which invites more infection. This concept, known as the “vicious cycle,” explains why bronchiectasis is progressive in many people even after the original trigger is long gone.
The inflammation isn’t limited to the large airways you can see on a CT scan. The smaller airways deeper in the lungs also become infiltrated with immune cells that form clusters in the airway walls. This small-airway involvement is a major reason people with bronchiectasis experience airflow obstruction, the feeling that it’s hard to fully exhale.
Common Causes
Bronchiectasis is broadly divided into two categories: cases linked to cystic fibrosis (CF) and everything else, collectively called non-CF bronchiectasis. Non-CF bronchiectasis is far more common and has a long list of possible triggers.
Prior lung infections are among the most frequent causes. A severe bout of pneumonia, tuberculosis, or infection with a group of bacteria called nontuberculous mycobacteria can leave enough airway damage to set the vicious cycle in motion. Immune system problems, such as common variable immunodeficiency, make people vulnerable to repeated infections that accumulate damage over time.
Autoimmune conditions like rheumatoid arthritis and inflammatory bowel disease are also associated with bronchiectasis, as are genetic conditions that affect airway defense, like primary ciliary dyskinesia (where the mucus-clearing hairs don’t work properly). According to U.S. data, nearly half of people with non-CF bronchiectasis also have gastroesophageal reflux disease, about 29% have asthma, and 20% have COPD.
Despite thorough testing, up to 38% of cases have no identifiable cause. These are labeled idiopathic, meaning the original trigger is unknown.
Symptoms to Recognize
The hallmark of bronchiectasis is a persistent, productive cough, typically lasting at least eight weeks, that brings up large amounts of sputum daily. The sputum often contains mucus, pus, and trapped particles, and it may be discolored (yellow, green, or brown) depending on the level of infection.
Beyond the cough, people commonly experience shortness of breath, wheezing, and fatigue. Some notice a crackling sound when they breathe. Coughing up blood (hemoptysis) can occur, ranging from small streaks in the sputum to more significant bleeding that requires urgent attention. Many people also deal with recurring chest infections, sometimes several times a year, each one potentially worsening the underlying airway damage.
Flare-ups, called exacerbations, are periods when symptoms suddenly worsen. You might notice your sputum increasing in volume or changing color, more breathlessness than usual, or a new fever. These episodes typically require antibiotics and are a major driver of the long-term decline in lung function.
How It’s Diagnosed
A high-resolution CT scan of the chest is the standard tool for confirming bronchiectasis. It shows the widened airways clearly and can reveal which pattern of dilation is present and how widespread it is. A regular chest X-ray can suggest the condition but isn’t detailed enough for a definitive diagnosis.
Once bronchiectasis is confirmed, your doctor will likely run additional tests to look for an underlying cause. These might include blood tests for immune function, sputum cultures to identify which bacteria are present, and sometimes genetic testing. Identifying a treatable cause, like an immune deficiency, can change the management approach significantly.
Bacteria That Take Hold
Because the airways can’t clear themselves properly, bacteria often take up permanent residence, a situation called chronic colonization. One of the most common and problematic colonizers is Pseudomonas aeruginosa, a hardy bacterium that forms protective biofilms and is difficult to eradicate once established. People colonized with Pseudomonas tend to experience faster lung function decline, more frequent exacerbations, and more hospitalizations compared to those without it.
Sputum cultures are an important part of ongoing care because knowing which bacteria are present guides antibiotic choices during flare-ups and helps identify when more aggressive treatment strategies are needed.
Daily Management and Airway Clearance
There is no cure for bronchiectasis, so treatment focuses on breaking the vicious cycle: clear the mucus, reduce infections, and control inflammation. The cornerstone of daily management is airway clearance therapy, a set of physical techniques designed to loosen and move mucus out of the damaged airways.
Several methods are used, and most people work with a respiratory physiotherapist to find the combination that suits them best. Gravity-assisted drainage involves positioning your body so that gravity helps mucus flow from specific lung segments toward the larger airways where it can be coughed out. The active cycle of breathing technique (ACBT) uses a pattern of relaxed breathing, deep breaths, and forced exhalations to mobilize mucus without causing airway collapse.
Devices can also help. Positive expiratory pressure (PEP) masks and handheld oscillating devices create resistance or vibration when you exhale, which helps prop open the airways and shake mucus loose. Studies have shown that these techniques reduce lung hyperinflation, with some approaches lowering trapped air volume by 19% to 30% compared to no treatment. High-frequency chest wall oscillation vests, which vibrate the chest externally, are another option, particularly for people who have difficulty with manual techniques.
Consistency matters more than the specific technique. Most people benefit from doing airway clearance at least once or twice daily, increasing the frequency during exacerbations when mucus production ramps up.
Medications and Long-Term Treatment
For people who experience frequent exacerbations (typically three or more per year), long-term antibiotic therapy can help break the infection cycle. European Respiratory Society guidelines strongly recommend long-term treatment with a class of antibiotics called macrolides for high-risk patients. These drugs work partly as antibiotics and partly as anti-inflammatory agents, reducing both bacterial load and airway inflammation.
For people with chronic Pseudomonas colonization who are at high risk of flare-ups, inhaled antibiotics delivered directly to the lungs are also strongly recommended. When Pseudomonas is first detected, eradication treatment may be attempted to prevent it from establishing permanent residence.
Mucoactive drugs, which thin or hydrate mucus to make it easier to clear, are recommended in specific situations. Inhaled corticosteroids, commonly used in asthma, are not recommended as routine treatment for bronchiectasis unless there’s a coexisting condition like asthma that warrants them.
Long-Term Outlook
Bronchiectasis is a lifelong condition, but its trajectory varies enormously. Some people have mild, stable disease that causes little more than a daily cough. Others experience progressive lung function decline punctuated by frequent infections. The key factors that tend to predict a worse outcome include Pseudomonas colonization, more extensive airway involvement on CT scans, frequent exacerbations, and more severe airflow obstruction at the time of diagnosis.
Lung function does tend to decline over time, though the rate varies. Each exacerbation carries the risk of further permanent damage, which is why preventing flare-ups is such a central goal of treatment. People who commit to daily airway clearance, stay on top of infections early, and work closely with a respiratory specialist generally have better long-term outcomes than those who treat the condition reactively.